Using a new method of indocyanine green for liver surgery imaging
Official title: Application of Indocyanine Green(ICG)@Human Serum Albumin(HSA) Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection: A Prospective, Double-Blinded, Randomized Controlled Trial
Run by West China Hospital · NCT06219096 · Data updated 2026-11-12
This study is testing a new way of using a special dye during liver surgery to see if it helps doctors find tumors better compared to the usual method, and it's for patients with liver cancer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | West China Hospital Academic / other |
| Locations | 1 site (Chengdu, Sichuan) |
| Status | Recruiting |
| Started | December 10, 2023 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2028 |
| Registry record updated | January 23, 2024 |
| Trial ID | NCT06219096 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 18-75 with primary liver malignancies who are scheduled for laparoscopic anatomical liver resection and have a Child-Pugh grade A or B liver function.
✕Probably not a fit
Patients with severe liver dysfunction, coagulation disorders, or those who are pregnant or lactating may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial is a single-center, prospective, randomized controlled trial comparing a novel indocyanine green (ICG) administration protocol with the standard protocol for fluorescence imaging during laparoscopic anatomical liver resection. The study will enroll 100 patients aged 18-75 with primary liver malignancies, randomly assigning them to either the experimental group using the new ICG-albumin protocol or the control group using the standard ICG protocol. The primary outcome will assess the efficacy of fluorescence imaging through a scoring system evaluated by independent experts. The goal is to enhance visualization of liver segments and tumor margins during surgery.
Why it matters
Potential benefit: If successful, this study could improve surgical outcomes by providing better visualization of liver tumors, potentially leading to more effective resections.
How similar studies have gone: Other studies have shown promising results with similar fluorescence imaging techniques, but this specific approach using ICG-albumin is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age: 18-75 years old, patients with hepatic malignancies who are undergoing laparoscopic anatomical liver resection; 2. Preoperative liver function Child-Pugh grade A or B; 3. No contraindications for laparoscopic liver resection; 4. Expected survival ≥3 months; 5. ECOG PS score 0-1; 6. Normal major organ functions, and meet the following laboratory test results within 7 days prior to enrollment: white blood cell (WBC) ≥2.5×10\^9/L, absolute neutrophil count (ANC) ≥1.5×10\^9/L, platelet (PLT) ≥75×10\^9/L, hemoglobin (HGB) ≥90g/L; NR ≤1.5xULN; serum creatinine (CT) ≤1.5xULN; total bilirubin (TBI) ≤1.5×upper limit of normal (ULN); 7. Patients voluntarily participate and sign informed consent. Exclusion Criteria: 1. No obvious ischemic demarcation line after intraoperative occlusion or disconnection of target hepatic pedicle, or the liver fluorescence reaches an intensity that interferes with surgery before intraoperative ICG injection. 2. Poor hepatic reserve function (ICG R15 ≥ 20%); 3. Severe cardiopulmonary diseases, intolerant to general anesthesia and surgery; 4. Moderate or large amount of symptomatic ascites or pleural effusion; 5. Active bleeding or coagulation abnormalities; 6. Hepatic encephalopathy; 7. Allergy to ICG; 8. History of gastrointestinal bleeding within the past 6 months or definite tendency for gastrointestinal bleeding; 9. Severe esophageal gastric varices requiring interventional treatment; 10. Objective evidence showing severe impaired pulmonary function such as pulmonary fibrosis; 11. Any significant clinical and laboratory abnormalities that the investigator considers affecting safety assessment.
Where it's running
-
West China Hospital
Chengdu, Sichuan, China Recruiting
Study contacts
- Study coordinator: Hong Wu, Professor
- Email: wuhong@scu.edu.cn
- Phone: 18980601958
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Postpartum exercise to improve heart and metabolic health in women at high risk for preeclampsia
This pilot study tests whether a 12‑week postpartum exercise program can improve heart health and metabolic markers in women who were at high risk for preeclampsia.
-
Suzetrigine for pain relief after knee replacement
This trial tests whether suzetrigine can reduce opioid use after a total knee replacement compared with placebo.
-
Early pregnancy lifestyle patterns and glucose changes in a TOFFFY sub-study
This study tests whether daily patterns like sleep, activity, and meal timing in early pregnancy affect glucose levels and the risk of gestational diabetes, using CGM and wearable data in pregnant women in Singapore.
-
Continuous monitoring and stepwise control of laryngeal mask airway cuff pressure to reduce throat problems after surgery in older adults
This trial will test whether continuously monitoring and progressively adjusting the inflatable laryngeal mask airway (LMA) cuff pressure reduces postoperative sore throat and swallowing problems in people aged 60 or older having elective non-thoracic, non-head-and-neck surgery.
-
Laser-guided visual feedback exercise program after lumbar microdiscectomy
We will test whether adding laser-pointer visual feedback to stabilization exercises helps adults recovering from lumbar microdiscectomy improve pain, function, and balance.
-
Oral Health Care During Pregnancy to Try to Improve Gum Health and Birth Outcomes
This study tests two noninvasive ways to improve dental health for pregnant people with gum disease, to see if better oral care can help pregnancy outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.